Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
British Journal of Haematology|March 25, 2021
Distinct bone marrow immunophenotypic features define the splicing factor 3B subunit 1 (SF3B1)-mutant myelodysplastic syndromes subtypeCarolien Duetz, Theresia M Westers, Florentien E M In 't Hout, et al.
Immunotherapy|November 6, 2013
Procedures for the expansion of CD14(+) precursors from acute myeloid leukemic cells to facilitate dendritic cell-based immunotherapyWillemijn van den Ancker, Pepijn G J B Wijnands, Jurjen M Ruben, et al.
Cytometry. Part B, Clinical Cytometry|December 30, 2021
ELN iMDS flow working group validation of the monocyte assay for chronic myelomonocytic leukemia diagnosis by flow cytometryOrianne Wagner-Ballon, Peter Bettelheim, Jeroen Lauf, et al.
Cytometry. Part B, Clinical Cytometry|August 23, 2024
The role of the primitive marker CD133 in CD34-negative acute myeloid leukemia for the detection of leukemia stem cellsTom Reuvekamp, Luca L G Janssen, Lok Lam Ngai, et al.
Cytometry. Part B, Clinical Cytometry|November 23, 2022
Multicenter prospective evaluation of diagnostic potential of flow cytometric aberrancies in myelodysplastic syndromes by the ELN iMDS flow working groupWolfgang Kern, Theresia M Westers, Frauke Bellos, et al.
Nature Communications|November 18, 2025
An inflammatory T-cell-stromal axis contributes to hematopoietic stem/progenitor cell failure and clonal evolution in human myelodysplastic syndromeLanpeng Chen, Yujie Bian, Eline Pronk, et al.
Genes, Chromosomes & Cancer|February 26, 2017
Genomic array as compared to karyotyping in myelodysplastic syndromes in a prospective clinical trialMarian J Stevens-Kroef, Daniel Olde Weghuis, Najat ElIdrissi-Zaynoun, et al.
Hemasphere|June 8, 2026
Prognostic value of measurable residual disease in high-risk MDS after intensive chemotherapy in HOVON-SAKK studiesCoen R Veenstra, Lok Lam Ngai, Patrycja Gradowska, et al.
Haematologica|September 24, 2016
Implementation of erythroid lineage analysis by flow cytometry in diagnostic models for myelodysplastic syndromesEline M P Cremers, Theresia M Westers, Canan Alhan, et al.
Oncotarget|November 2, 2017
Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditionsPeter Valent, Attilio Orazi, David P Steensma, et al.
Pageof 8